These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29479481)

  • 1. Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions.
    Horner C; Tenenbaum E; Sipp D; Master Z
    NPJ Regen Med; 2018; 3():5. PubMed ID: 29479481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action.
    Caulfield T; Murdoch B
    BMC Med Ethics; 2019 Aug; 20(1):51. PubMed ID: 31383026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions.
    Ogbogu U; Du J; Koukio Y
    BMC Med Ethics; 2018 May; 19(1):32. PubMed ID: 29716594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry Responsibilities in Tackling Direct-to-Consumer Marketing of Unproven Stem Cell Treatments.
    Master Z; Fu W; Paciulli D; Sipp D
    Clin Pharmacol Ther; 2017 Aug; 102(2):177-179. PubMed ID: 28695633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Between the court and the clinic: lawsuits for medicines and the right to health in Brazil.
    Biehl J; Amon JJ; Socal MP; Petryna A
    Health Hum Rights; 2012 Jun; 14(1):E36-52. PubMed ID: 22773096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying lessons from tobacco litigation to obesity lawsuits.
    Alderman J; Daynard RA
    Am J Prev Med; 2006 Jan; 30(1):82-8. PubMed ID: 16414429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating the advertising and promotion of stem cell therapies.
    von Tigerstrom B
    Regen Med; 2017 Oct; 12(7):815-826. PubMed ID: 29112482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Academic physician specialists' views toward the unproven stem cell intervention industry: areas of common ground and divergence.
    Smith C; Crowley A; Munsie M; DeMartino ES; Staff NP; Shapiro S; Master Z
    Cytotherapy; 2021 Apr; 23(4):348-356. PubMed ID: 33563545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Farewell to Falsity: Shifting Standards in Medicare Fraud Enforcement.
    Buck ID
    Seton Hall Law Rev; 2019; 49(1):1-51. PubMed ID: 30557921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
    Douglas CE; Davis RM; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing persuasive health education for patients seeking unproven stem cell interventions.
    Kawam O; Zhu X; Eton DT; Martin-Lillie C; Finney Rutten LJ; Shapiro S; Tilburt JC; Master Z
    Stem Cell Reports; 2023 Aug; 18(8):1549-1554. PubMed ID: 37557072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislation.
    Matthews KRW; Lowe SJ; Master Z
    Cytotherapy; 2024 Apr; 26(4):404-409. PubMed ID: 38310500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Law as a tool to promote healthcare safety.
    Ramanathan T
    Clin Gov; 2014; 19(2):172-180. PubMed ID: 26855615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the margins to mainstream: How providers of autologous 'stem cell treatments' legitimise their practice in Australia.
    MacGregor C; Petersen A; Munsie M
    Health (London); 2021 Jan; 25(1):51-68. PubMed ID: 31081381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care fraud and abuse.
    Kalb PE
    JAMA; 1999 Sep 22-29; 282(12):1163-8. PubMed ID: 10501120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The two-bucket problem of unproven stem cell interventions.
    Master Z
    Regen Med; 2023 Jan; 18(1):19-21. PubMed ID: 36221994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal intervention against medical accidents in Japan.
    Yasunaga H
    Risk Manag Healthc Policy; 2008; 1():39-42. PubMed ID: 22312202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Hospital Lawsuits Filed Against Patients for Unpaid Bills Following Published Research About This Activity.
    Paturzo JGR; Hashim F; Dun C; Boctor MJ; Bruhn WE; Walsh C; Bai G; Makary MA
    JAMA Netw Open; 2021 Aug; 4(8):e2121926. PubMed ID: 34424301
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.